MedicinehospitalEssential

Meningococcal Meningitis Vaccine

A vaccine (Penbraya) protecting against meningococcal disease groups A, B, C, W and Y.

Clinical information

Common uses

prevention of invasive meningococcal disease (ages 10-25)

Common side effects

pain at the injection site
fatigue
headache
muscle pain
injection-site redness or swelling

Cautions

not after a severe allergic reaction to any component

Pregnancy: no clinical data in pregnancy

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Penbraya (meningococcal groups A, B, C, W, Y vaccine) label, setid fd5652b6-5ae4-437e-a456-47deaf500794 (accessed 2026-08-16)

Approved brands & formulations2

Brand name	Dosage form	Strength	Importer	Category
Menningococcal Meningitis Vaccine	Parenteral ( Vaccine )	50mcg of purified polysaccaride of N.menigitidis group A and C 0.5ml/	—	hospital
Vaccine Meningitis	Parenteral ( Injection )	50mcg of purified polysaccaride of N.menigitidis group A and C 0.5ml/	—	hospital